Electronic Health Data for Postmarket Surveillance: A Vision Not Realized Thomas J. MooreCurt D. Furberg Current Opinion 30 May 2015 Pages: 601 - 610
DNA Barcoding and Pharmacovigilance of Herbal Medicines Hugo J. de BoerMihael C. IchimSteven G. Newmaster Leading Article 16 June 2015 Pages: 611 - 620
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance Priya BahriAlexander N. DodooPeter G. Mol From the ISoP 02 June 2015 Pages: 621 - 627
Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia Woldesellassie M. BezabheLuke R. BereznickiGregory M. Peterson Original Research Article 26 May 2015 Pages: 629 - 639
Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis Yoshinori TakeuchiKazuhiro KajiyamaYoshiaki Uyama Original Research Article 23 May 2015 Pages: 641 - 650
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study Aizati N. A. DaudJorieke E. H. BergmanBob Wilffert Original Research Article Open access 29 May 2015 Pages: 651 - 659
Preventability of Voluntarily Reported or Trigger Tool-Identified Medication Errors in a Pediatric Institution by Information Technology: A Retrospective Cohort Study Jeremy S. StultzMilap C. Nahata Original Research Article 27 May 2015 Pages: 661 - 670
Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study Artur AkbarovEvangelos KontopantelisDarren M. Ashcroft Original Research Article Open access 23 June 2015 Pages: 671 - 682